Article

Lymphangioleiomyomatosis: what do we know and what are we looking for?

Unità Operativa di Pneumologia e Terapia Semi-Intensiva Respiratoria--Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare Ospedale San Giuseppe, via San Vittore 12, Milan, Italy.
European Respiratory Review 03/2011; 20(119):34-44. DOI: 10.1183/09059180.00011010
Source: PubMed

ABSTRACT Lymphangioleiomyomatosis (LAM) is a rare disease characterised by proliferation of abnormal smooth muscle-like cells (LAM cells) leading to progressive cystic destruction of the lung, lymphatic abnormalities and abdominal tumours. It affects predominantly females and can occur sporadically or in patients with tuberous sclerosis complex. This review describes the recent progress in our understanding of the molecular pathogenesis of the disease and LAM cell biology. It also summarises current therapeutic approaches and the most promising areas of research for future therapeutic strategies.

0 Followers
 · 
157 Views

Preview

Download
1 Download
Available from